rivaroxaban
Showing 1 - 25 of 153
Atrial Fibrillation, Coronary Artery Disease Trial (Rivaroxaban)
Not yet recruiting
- Atrial Fibrillation
- Coronary Artery Disease
- Rivaroxaban
- (no location specified)
Oct 22, 2023
Acute Coronary Syndrome Trial (rivaroxaban)
Not yet recruiting
- Acute Coronary Syndrome
- rivaroxaban
- (no location specified)
Feb 20, 2023
Ischemic Stroke, Intracranial Atherosclerosis, Stenosis Trial (Rivaroxaban, Clopidogrel, Aspirin)
Not yet recruiting
- Ischemic Stroke
- +2 more
- Rivaroxaban
- +3 more
- (no location specified)
Jan 17, 2023
Atrial Fibrillation, Acute Coronary Syndrome Trial in Ottawa (Ticagrelor, Rivaroxaban)
Active, not recruiting
- Atrial Fibrillation
- Acute Coronary Syndrome
- Ticagrelor
- Rivaroxaban
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Jan 12, 2023
Left Ventricular Thrombus, Myocardial Infarction Trial (Rivaroxaban, Warfarin)
Not yet recruiting
- Left Ventricular Thrombus
- Myocardial Infarction
- Rivaroxaban
- Warfarin
- (no location specified)
Mar 31, 2023
Radial Artery Occlusion Trial in Rochester (Rivaroxaban)
Not yet recruiting
- Radial Artery Occlusion
- Rivaroxaban
-
Rochester, MinnesotaMayo Clinic Rochester
Aug 16, 2022
Multiple Myeloma in Relapse, Multiple Myeloma Progression, Multiple Myeloma Stage II Trial in London (Rivaroxaban, ASA)
Recruiting
- Multiple Myeloma in Relapse
- +5 more
- Rivaroxaban
- ASA
-
London, Ontario, CanadaLondon Health Sciences Centre
Oct 3, 2022
Chronic Hemodialysis Patients Trial (Rivaroxaban)
Not yet recruiting
- Chronic Hemodialysis Patients
- Rivaroxaban
- (no location specified)
Jun 2, 2022
Ventricular Mural Thrombosis Trial in Beijing (Rivaroxaban)
Recruiting
- Ventricular Mural Thrombosis
- Rivaroxaban
-
Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Sciences & Pecking Un
Jun 24, 2022
Healthy Trial in Saint-etienne (Rivaroxaban, Activated charcoal)
Recruiting
- Healthy
- Rivaroxaban
- Activated charcoal
-
Saint-etienne, FranceCHU de SAINT-ETIENNE
Feb 14, 2022
Valvular Heart Disease Trial in São Paulo (Rivaroxaban, Warfarin)
Completed
- Valvular Heart Disease
- Rivaroxaban
- Warfarin
-
São Paulo, SP, BrazilAssociação do Sanatório Sírio - Hospital do Coração HCor
Apr 4, 2022
Cerebral Infarction, TIA Trial in Shenyang (Rivaroxaban)
Recruiting
- Cerebral Infarction
- TIA
- Rivaroxaban
-
Shenyang, ChinaGeneral Hospital of ShenYang Military Region
Feb 20, 2022
Atrial Fibrillation Trial in Ottawa (Apixaban, Rivaroxaban)
Recruiting
- Atrial Fibrillation
- Apixaban
- Rivaroxaban
-
Ottawa, Ontario, CanadaThe Ottawa Hospital - General Campus
Mar 14, 2022
Infarction Volume on Hemorrhagic Transformation in Ischemic
Recruiting
- Cerebrovascular Stroke
- +3 more
- Rivaroxaban
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital, School of Medicine, Zhejiang Univers
May 5, 2022
Venous Thromboembolism Trial in Canada (Apixaban, Rivaroxaban)
Completed
- Venous Thromboembolism
- Apixaban
- Rivaroxaban
-
Edmonton, Alberta, Canada
- +3 more
Mar 21, 2022
Prophylactic and Therapeutic Anticoagulants in Egyptian COVID-19
Completed
- Covid19
- +2 more
- Enoxaparin
- +2 more
-
Cairo, Please Select, EgyptTeachers Hospital
Jul 19, 2022
Prevention of Venous Thromboembolism Trial in Italy (Rivaroxaban, Placebo)
Completed
- Prevention of Venous Thromboembolism
- Rivaroxaban
- Placebo
-
Pozzuoli, Napoli, Italy
- +16 more
Mar 10, 2022
Anticoagulation in Venous Thromboembolism and Cancer
Active, not recruiting
- Neoplasms
- Embolism
- Apixaban
- +5 more
-
London, United KingdomPfizer Investigational Site
Nov 17, 2022
Cancer, Rivaroxaban, Venous Thromboembolism Trial in Santo André (Rivaroxaban, Enoxaparin)
Recruiting
- Cancer
- +3 more
- Rivaroxaban
- Enoxaparin
-
Santo André, São Paulo, BrazilScience Valley Research Institute
Aug 3, 2021
Atherosclerosis Trial in Torrance (rivaroxaban, Warfarin)
Completed
- Atherosclerosis
- rivaroxaban
- Warfarin
-
Torrance, CaliforniaLos Angeles Biomedical Research Institute
Jul 21, 2021
Medicines That Help in Thinning Blood in People With Atrial
Not yet recruiting
- Atrial Fibrillation
- No OAC
- +4 more
- (no location specified)
Apr 28, 2023
Acute Coronary Syndrome, Left Ventricular Thrombus Trial in Karachi (Rivaroxaban, Warfarin)
Recruiting
- Acute Coronary Syndrome
- Left Ventricular Thrombus
- Rivaroxaban
- Warfarin
-
Karachi, Sindh, PakistanNational Institute of Cardiovascular Diseases
Jul 10, 2021